Late manifestation of chronic liver disease in adults with alpha-1-antitrypsin deficiency

Jorge Rakela, Markus Goldschmiedt, Jurgen Ludwig

Research output: Contribution to journalArticle

34 Scopus citations

Abstract

A review of 19 adult patients with alpha-1-antitrypsin deficiency (A1AT deficiency) and chronic liver disease revealed a late onset of symptomatic hepatic abnormalities in this condition. Thirteen patients (68%) were 60 years or older when the liver disease was discovered. The mean age of the patients with the ZZ, SZ, and MZ phenotypes was 58, 66, and 72.5 years, respectively; this suggested a later onset of the liver disease in the heterozygotes. At the time of diagnosis, the hepatic condition usually was advanced; in eight patients (42%) the survival was less than two years. The most important associated condition was chronic obstructuve lung disease which was found in 10 patients (53%). We conclude that advanced age and the high incidence of obstructive lung disease make it unlikely that liver transplantation will become a common therapeutic option for adult patients with A1AT deficiency and associated liver disease. Periodic screening of liver function may be indicated in patients with A1AT deficiency so that chronic liver disease can be diagnosed early, particularly if current attempts to develop effective medical therapy for this condition are successful.

Original languageEnglish (US)
Pages (from-to)1358-1362
Number of pages5
JournalDigestive Diseases and Sciences
Volume32
Issue number12
DOIs
Publication statusPublished - Dec 1 1987
Externally publishedYes

    Fingerprint

Keywords

  • alpha-1-antitrypsin deficiency
  • liver transportation selection
  • screening

ASJC Scopus subject areas

  • Physiology
  • Gastroenterology

Cite this